CareSynergy

See the following -

Zoeticx Challenges Lack of Interoperability with Open Middleware Technology

Zoeticx software bridges the gap between medical data and quality patient care. The company offers software solutions for the healthcare industry which are dedicated to Improving Patient Outcomes®, enhancing the quality of care, containing costs, and simplifying administration. These solutions offer an immediate increase in the quality of care by delivering the right information to the right caregiver at the right time, in a manner that can be easily understood.  In making an impact on a new healthcare landscape ushered in by Obamacare and the medical industry itself, Zoeticx champions new paradigms through innovation with a patient-centric approach.  Its solutions are unique to their ability to address these problems. Read More »

Zoeticx Expands into Asian-Pacific Healthcare Channel

Press Release | Zoeticx | June 8, 2015

Zoeticx, Inc., the developer of medical software that bridges the gap between medical data and quality patient care, today announced its entry into the rapidly growing 150 billion Asia-Pacific healthcare markets, a dynamic medical landscape with an accelerated evolution driven by innovation and opportunities expected through 2020. Zoeticx will offer its Patient Clarity Platform, EHR integration middleware software designed to support the next generation of healthcare innovative applications, to medical facilities across ASEAN locations.  The software will be distributed as part of a reseller agreement with Telco Time, a business outsourcing organization based in Yokohama.

Read More »

Zoeticx Opens Its API To Third-Party Developers

Press Release | Zoeticx | May 6, 2014

Zoeticx, Inc., the developer of medical software that bridges the gap between medical data and quality patient care, today opened its application programming interface (API) to meet the demands of medical industry software developers wanting to build applications that require access to patient medical records...

Read More »